Berlin-Based Infarm Hires Goldman to Pursue Potential SPAC Deal

Infarm

German vertical farming start-up Infarm has hired Goldman Sachs to help with talks on the possibility of going public through a merger with a SPAC as it seeks funds for expansion, Just Food reports.

Berlin-based Infarm, which currently focuses on indoor production of herbs and salad greens, uses cloud-computing to manage the cultivation of produce that is grown close to consumers, minimising its environmental impact. A potential merger could give it a valuation of more than $1 billion. Read more.

Total
0
Shares
Related Posts
Thimble Point Acquisition
Read More

Pear Therapeutics Seeking a Financial Lifeline

Pear Therapeutics went public in December 2021 in a $1.6 billion deal with Thimble Point Acquisition. It has seen its share price go from a high of trading at $5.22 per share to penny stock value, hovering around 49 cents a share.